Open Beta
TREN
MetriLume
TREN

US marketsASMB

SEC-sourced researchBeta

ASMB

ASSEMBLY BIOSCIENCES, INC.

Company comparison ↗

Data passport

CIK
0001426800
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Aug 20, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 28,520,000.0000 USD; December 2025: 72,303,000.0000 USD72.3M USD0 USD0December 2024December 2025
ASMB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202428,520,000.0000Mar 19, 2026
December 202572,303,000.0000Mar 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202572,303,000.0000-6,122,000.0000-41,093,000.0000257,590,000.000050,839,000.0000Mar 19, 2026
December 202428,520,000.0000-40,177,000.0000-51,117,000.0000119,168,000.000085,809,000.0000Mar 19, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

63/100
Profitability33
Growth100
Balance sheet80
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$72.3MJan 1, 2025 – Dec 31, 2025Mar 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$28.52MJan 1, 2024 – Dec 31, 2024Mar 19, 202610-K
Net incomeNetIncomeLoss-$6.12MJan 1, 2025 – Dec 31, 2025Mar 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$41.09MJan 1, 2025 – Dec 31, 2025Mar 19, 202610-K
Total assetsAssets$257.59MDec 31, 2025Mar 19, 202610-K
Total liabilitiesLiabilities$50.84MDec 31, 2025Mar 19, 202610-K

New filings

Explore methodology ↗